Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AMOVA ASSET MANAGEMENT ASIA LIMITED (93U)

  • SEC News
  • April 30, 2026, 09:42 UTC
  • 0
  • 0 comments

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

Comment Full text

AMOVA ASSET MANAGEMENT ASIA LIMITED (93U)

  • SEC News
  • April 30, 2026, 09:42 UTC
  • 0
  • 0 comments

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

Comment Full text

OVERSEA-CHINESE BANKING CORPORATION LIMITED (O39)

  • SEC News
  • April 30, 2026, 09:42 UTC
  • 0
  • 0 comments

Employee Stock Option/ Share Scheme: Notice of Use of Treasury Shares

Comment Full text

AMOVA ASSET MANAGEMENT ASIA LIMITED (93U)

  • SEC News
  • April 30, 2026, 09:42 UTC
  • 0
  • 0 comments

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

Comment Full text

AMOVA ASSET MANAGEMENT ASIA LIMITED (93U)

  • SEC News
  • April 30, 2026, 09:42 UTC
  • 0
  • 0 comments

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

Comment Full text

CAPITALAND INTEGRATED COMMERCIAL TRUST MANAGEMENT LIMITED (C38U)

  • SEC News
  • April 30, 2026, 09:41 UTC
  • 0
  • 0 comments

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Change in Interest of Substantial Unitholders: CLG and CLA

Comment Full text

CHINA INTERNATIONAL HOLDINGS LIMITED (BEH)

  • SEC News
  • April 30, 2026, 09:41 UTC
  • 0
  • 0 comments

Annual Reports and Related Documents:

Comment Full text

JB FOODS LIMITED (BEW)

  • SEC News
  • April 30, 2026, 09:41 UTC
  • 0
  • 0 comments

Change - Announcement of Appointment: Appointment of Chief Commercial Officer

Comment Full text

ANNICA HOLDINGS LIMITED (5AL)

  • SEC News
  • April 30, 2026, 09:41 UTC
  • 0
  • 0 comments

General Announcement: Minutes of Extraordinary General Meeting held on 9 April 2026

Comment Full text

IHH HEALTHCARE BERHAD (Q0F)

  • SEC News
  • April 30, 2026, 09:40 UTC
  • 0
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Comment Full text
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Search

News categories

  • Technical Exchange News(12156)
  • Event(5779)
  • SEC News(257915)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152430)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin